ACCC flags ‘significant concerns’ with Cochlear’s $170M acquisition of Oticon Medical
ACCC 2022-12-01 5:09 pm By Christine Caulfield
Please login to bookmark Close

The competition regulator has detailed “significant” concerns with Cochlear’s proposed acquisition of Oticon Medical, saying Thursday a tie-up would cut to three the number of cochlear implant suppliers in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au